GE HealthCare Technologies and UW-Madison, which have collaborated for years on scientific and technological advancements, formalized a new 10-year strategic agreement they say will take them to new frontiers in digital technologies and disease-focused solutions.

The two organizations said their combined future efforts could drive improved diagnosis and disease management through developments in magnetic resonance (MR), computed tomography (CT), ultrasound, interventional radiology and molecular imaging.

Their work will include a focus on Theranostics, a future advanced treatment option that combines diagnostic technology and therapeutics to manage diseases such as prostate cancer.

Click here to read the full article.